Home/Filings/4/0001831283-23-000052
4//SEC Filing

Wang Yizhe 4

Accession 0001831283-23-000052

CIK 0001831283other

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 4:18 PM ET

Size

5.0 KB

Accession

0001831283-23-000052

Insider Transaction Report

Form 4
Period: 2023-03-29
Wang Yizhe
DirectorChief Executive Officer
Transactions
  • Award

    Ordinary Shares

    2023-03-29+907,498907,498 total
Footnotes (1)
  • [F1]Represents restricted share units granted to the Reporting Person under the LianBio 2021 Equity Incentive Plan. Each restricted share unit represents the contingent right to receive one share of the Issuer's Ordinary Shares. 25% of the restricted share units shall vest on March 29, 2024; the remainder shall vest in 25% annual installments such that the restricted share units are fully vested on March 29, 2027, subject to the Reporting Person providing continuous service to the Issuer on each such date.

Issuer

LianBio

CIK 0001831283

Entity typeother

Related Parties

1
  • filerCIK 0001884248

Filing Metadata

Form type
4
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 4:18 PM ET
Size
5.0 KB